The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection

The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection Publisher Pubmed

Faghihkhorasani A¹ ; Ahmed HH² ; Mashool NM³ ; Alwan M⁴ ; Assefi M⁵ ; Adab AH⁶ ; Yasamineh S⁷ ; Gholizadeh O⁸ ; Baghani M⁹

Source: Virology Journal Published:2023

Abstract

Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus. Graphical Abstract: [Figure not available: see fulltext.] © 2023, BioMed Central Ltd., part of Springer Nature.

Related Docs

View other Related Docs

1. The Potential Use of Bacteria and Their Derivatives As Delivery Systems for Nanoparticles in the Treatment of Cancer, Journal of Drug Targeting (2025)

2. Recent Advances on High-Efficiency of Micrornas in Different Types of Lung Cancer: A Comprehensive Review, Cancer Cell International (2023)

3. Bacterial Components As Naturally Inspired Nano-Carriers for Drug/Gene Delivery and Immunization: Set the Bugs to Work?, Biotechnology Advances (2018)

Experts (# of related papers)

SeyedMohamad Hosseini Hooshiyar (2)

Hossein Gandomkar (1)

Style	Citing Format
MLA	Faghihkhorasani A, et al.. "The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection." Virology Journal, vol. 20, no. 1, 2023, pp. -.
APA	Faghihkhorasani A, Ahmed HH, Mashool NM, Alwan M, Assefi M, Adab AH, Yasamineh S, Gholizadeh O, Baghani M (2023). The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection. Virology Journal, 20(1), -.
Chicago	Faghihkhorasani A, Ahmed HH, Mashool NM, Alwan M, Assefi M, Adab AH, Yasamineh S, Gholizadeh O, Baghani M. "The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection." Virology Journal 20, no. 1 (2023): -.
Harvard	Faghihkhorasani A et al. (2023) 'The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection', Virology Journal, 20(1), pp. -.
Vancouver	Faghihkhorasani A, Ahmed HH, Mashool NM, Alwan M, Assefi M, Adab AH, et al.. The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection. Virology Journal. 2023;20(1):-.
BibTex	@article{ author = {Faghihkhorasani A and Ahmed HH and Mashool NM and Alwan M and Assefi M and Adab AH and Yasamineh S and Gholizadeh O and Baghani M}, title = {The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection}, journal = {Virology Journal}, volume = {20}, number = {1}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Faghihkhorasani A AU - Ahmed HH AU - Mashool NM AU - Alwan M AU - Assefi M AU - Adab AH AU - Yasamineh S AU - Gholizadeh O AU - Baghani M TI - The Potential Use of Bacteria and Bacterial Derivatives As Drug Delivery Systems for Viral Infection JO - Virology Journal VL - 20 IS - 1 SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Abstract